Zomanex

Zomanex is a specialty pharmaceutical company revolutionizing cancer treatment with its Orazom drug delivery platform. Its flagship product, Orazom 3907, utilizes this innovative technology to administer Paclitaxel, a widely-used cancer medication, orally. By enabling the effective absorption of hydrophobic compounds in the small intestine, Zomanex eliminates the need for traditional IV or injectable forms of medication. This proprietary drug delivery system has the potential to redefine the way cancer treatments are administered and make them more accessible to a broader patient population. As of now, we await further details on Zomanex's founding date, headquarters, and recent investments and investors. However, this pioneering approach places Zomanex at the forefront of the Biotechnology and Pharmaceutical industries.